[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369739-105":59,"doc-detail-369739-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-preliminary-assessment-of-a-stool-based-microrna-profile-for-early-colorectal-cancer-screening","A preliminary assessment of a stool-based microRNA profile for early colorectal cancer screening","","Colorectal cancer screening is dominated by non-invasive fecal occult blood testing, yet limited sensitivity for precancerous lesions drives the search for alternative biomarkers. This study evaluates stool-based microRNA (miR) profiles to detect early colorectal cancer and advanced precancerous lesions. A miR panel (miR-21-5p, miR-199a-5p, and age) shows moderate diagnostic performance, while an expanded panel including miR-451a, miR-21-5p, miR-199a-5p, age, and gender shows higher discrimination. Positive results yield improved sensitivity for high-grade dysplasia identification, and negative results after positive FOBT accurately identify individuals without lesions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-preliminary-assessment-of-a-stool-based-microrna-profile-for-early-colorectal-cancer-screening/369739/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-preliminary-assessment-of-a-stool-based-microrna-profile-for-early-colorectal-cancer-screening/369739.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in colorectal cancer screening?","Question",{"text":112,"@type":113},"Fecal occult blood testing has limited sensitivity for detecting precancerous lesions, motivating the need for additional non-invasive tools.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which microRNA panels were evaluated for early detection?",{"text":117,"@type":113},"One panel included miR-21-5p, miR-199a-5p, and age, and a broader panel added miR-451a plus gender, alongside miR-21-5p, miR-199a-5p, and age.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the panels perform for high-grade dysplasia lesions?",{"text":121,"@type":113},"The expanded panel showed high performance for discriminating high-grade dysplasia lesions, and when a positive result occurred in either panel the sensitivity for high-grade dysplasia identification reached 96%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369739,1790282607,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nA preliminary assessment of astool-based microRNA profile for early colorectal cancer screening  \nDanielaA. R. Santos1,2,3, Mariana Eiras1,3, Miguel Gonzalez-Santos1, Marlene Santos4,5,6, Carina Pereira7, Lúcio Lara Santos1,8, Mário Dinis-Ribeiro2,7,9 & Luís Lima1􀀍  \nColorectal cancer screening methods are well established worldwide as a fundamental pilar in  \nCRC management, namely through non-invasive faecal occult blood testing. However, the limited sensitivity of faecal occult blood test for detecting precancerous lesions highlights the need to search for alternative tools, such as microRNAs (miRs). The main aim of this study was to identify stoolbased miR profiles for early colorectal cancer detection. A panel with miR-21-5p, miR-199a-5p, and age showed a moderate performance for colorectal cancer detection (sensitivity: 88%). Additionally, miR-451a, miR-21-5p, miR-199a-5p, age, and gender showed high performance for discriminating high-grade dysplasia lesions (sensitivity: 91%) . Moreover, when we obtained a positive result in either panel, we achieved a sensitivity of 96% for high-grade dysplasia lesions identification. Finally, when a negative result was obtained in these panels after a positive faecal occult blood test result, we accurately identified individuals without lesions. These findings demonstrate the potential of miR panels as non-invasive biomarkers for colorectal cancer and high-grade dysplasia lesions detection and could constitute a secondary screening method following a positive faecal occult blood test.  \nColorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related death worldwide1. Several European countries have implemented population-based CRC screening programs, mainly based on a two-step approach: a non-invasive faecal occult blood test (FOBT) followed by a confirmatory colonoscopy, the gold standard method for screening2,3. Although FOBTis the most widely used test, its sensitivity is suboptimal (approximately 70–80% for malignant lesions and 30–40% for precancerous lesions), restricting the overall effectiveness of screening4–6. Colonoscopy remains the gold standard method for CRC screening due to its high sensitivity in detecting premalignant and cancerous lesions3,7. Nonetheless, colonoscopy is an invasive procedure, which presents inherent limitations, such as low patient adherence and high medical and economic burden8,9. These limitations underscore the crucial need to develop new, effective, and non-invasive screening tools to enhance CRC detection and reduce disease burden.  \nIn this context, numerous molecules have been recently reported as potential new biomarkers for CRC screening, with microRNAs (miRs) emerging as some of the most promising candidates10, 11. MiRs are short noncoding RNAs (18–24 nucleotides) that negatively regulate post-transcriptional gene expression12. Several studies have reported altered miR expression levels throughout CRC progression11. Furthermore, miR’s expression levels can be easily detected in biofluids such as stool, making them potential non-invasive biomarkers for CRC screening13, 14.  \nBuilding on our team’s literature review on miRs associated with CRC early detection15 this study evaluates eight miR candidates (miR-21-5p, miR-92a-3p, miR-135b-5p, miR-451a, and miR-421—previously evaluated in  \n1Experimental Pathology and Therapeutics Group, Research Centre of IPO Porto (CI- IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (Porto. CCC), Porto 4200-072, Portugal. 2Faculty of Medicine of the University of Porto (FMUP), Porto 4200-319, Portugal. 3Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto 4050-313, Portugal.  \n4School of Health, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida, 400, Porto 4200-07","cbCailIa40gjrqLR","https://ap.wps.com/l/cbCailIa40gjrqLR","pdf",1785306,"English","# Abstract\n# Introduction\n# Results\n## Study population\n## MicroRNA expression levels in stool samples\n# Methods and analysis\n# Discussion and conclusions","[{\"question\":\"What problem does the study address in colorectal cancer screening?\",\"answer\":\"Fecal occult blood testing has limited sensitivity for detecting precancerous lesions, motivating the need for additional non-invasive tools.\"},{\"question\":\"Which microRNA panels were evaluated for early detection?\",\"answer\":\"One panel included miR-21-5p, miR-199a-5p, and age, and a broader panel added miR-451a plus gender, alongside miR-21-5p, miR-199a-5p, and age.\"},{\"question\":\"How did the panels perform for high-grade dysplasia lesions?\",\"answer\":\"The expanded panel showed high performance for discriminating high-grade dysplasia lesions, and when a positive result occurred in either panel the sensitivity for high-grade dysplasia identification reached 96%.\"}]","A preliminary assessment of a stool-based microRNA profile for early colorectal cancer screening | PDF",1790184304,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e8fe7793c132024c8a904b62f3be872.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc05a4f97e6fc0e470709974201e70f9.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7384682d65b008b25eec340961e98677.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98fc802b85722422df7dc5223f62dc39.webp",980,1287]